PYQ Vault

A-R: ADA patient needs periodic infusion of engineered lymphocytes

The same question, asked 2 times: 2023*, 2025. Every wording below, oldest first.

Try each one first, then open its answer.

  1. Question 1

    2023

    Two statements are given, one labelled Assertion (A) and the other labelled Reason (R). Select the correct answer from the options given below.
    13
    Assertion (A) : A patient of ADA deficiency undergoing treatment for gene therapy requires periodic infusion of genetically engineered lymphocytes. Reason (R) : Lymphocytes are immortal.

    Tap an option to check your answer.

  2. Question 2

    2025

    Two statements are given, one labelled Assertion (A) and the other labelled Reason (R). Select the correct answer from the options given below.
    16
    Assertion (A) : A patient of ADA-deficiency requires periodic or repeated infusion of genetically-engineered lymphocytes. Reason (R) : Lymphocytes are not immortal, but have life span.

    Tap an option to check your answer.